73 related articles for article (PubMed ID: 3432764)
21. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
22. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
23. Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.
Vignal CV; Lourenço DM; Noguti MA; Chauffaille Mde L; Kerbauy J
Sao Paulo Med J; 1997; 115(6):1575-9. PubMed ID: 9640794
[TBL] [Abstract][Full Text] [Related]
24. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
25. Test of platelet function.
Bowie EJ; Owen CA
Vox Sang; 1981; 40 Suppl 1():36-47. PubMed ID: 7027625
[No Abstract] [Full Text] [Related]
26. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
Viero P; Cortelazzo S; Barbui T
Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
[No Abstract] [Full Text] [Related]
27. Recombinant human erythropoietin shortens the bleeding time and corrects the abnormal platelet aggregation in hemodialysis patients.
el-Shahawy MA; Francis R; Akmal M; Massry SG
Clin Nephrol; 1994 May; 41(5):308-13. PubMed ID: 8050212
[TBL] [Abstract][Full Text] [Related]
28. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
29. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
30. The clinical relevance of platelet aggregation study in myeloproliferative disorders.
Kueh YK; Chan L; Lim BC; Suri R; Tan YO
Ann Acad Med Singap; 1983 Jul; 12(3):466-71. PubMed ID: 6611104
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of spontaneous platelet aggregation by electrical impedance method of whole-blood aggregometer].
Yonemitsu H
Rinsho Byori; 1986 Dec; 34(12):1422-6. PubMed ID: 3560473
[No Abstract] [Full Text] [Related]
32. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
[TBL] [Abstract][Full Text] [Related]
33. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
34. [Platelet defects in chronic myeloproliferative disorders].
Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
[TBL] [Abstract][Full Text] [Related]
35. [Effect of epidural bupivacaine on platelet aggregation and bleeding time].
Fernández PJ; García M; Iravedra JA; Caballero J; González de Zárate J; Moreno Rodríguez L
Rev Esp Anestesiol Reanim; 1988; 35(1):15-8. PubMed ID: 3353545
[No Abstract] [Full Text] [Related]
36. [The assessment of platelet function in patients with essential thrombocythemia].
Treliński J; Tybura M; Chojnowski K
Pol Merkur Lekarski; 2008 Jul; 25(145):19-22. PubMed ID: 18839608
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
38. Platelet function after busulphan in chronic myeloproliferative disorders.
Barbui T; Bassan R; Viero P; Cortelazzo S; Dini E
Haematologica; 1983; 68(4):469-77. PubMed ID: 6414897
[No Abstract] [Full Text] [Related]
39. [The influence of pipemidic acid on epinephrine and collagen induced platelet aggregation in vitro].
Reuter HD; Thiele S
Arzneimittelforschung; 1985; 35(8):1326-9. PubMed ID: 4074448
[TBL] [Abstract][Full Text] [Related]
40. An unusual platelet function defect: report of 19 cases.
Saxena R; Gupta M; Gupta S; Choudhry VP
Indian J Pathol Microbiol; 2003 Oct; 46(4):576-8. PubMed ID: 15025347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
